Epigenetics;Cancer;Colorectal Cancer;EZH2;DMNT;clinical trial;combination cancer therapies

Combining Epigenetic Cancer Medications May Have Benefit for Colorectal Cancers and Other Tumor Types

[ad_1] Newswise — GRAND RAPIDS, Mich. (March 27, 2024) — A pair of medications that make malignant cells act as if they…